JILLIAN SULLIVAN: Open Payments
NPI 1639423734 · FARMINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,314 in 73 payments from 16 companies in 2025. Trend: 2023 $172 · 2024 $622 · 2025 $1,314
Food & beverage: $1,314
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $322 |
| Lilly USA, LLC | 7 | $147 |
| GlaxoSmithKline, LLC. | 5 | $128 |
| Astellas Pharma US Inc | 5 | $118 |
| Merck Sharp & Dohme LLC | 1 | $103 |
| Novo Nordisk Inc | 4 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $92 |
| Exact Sciences Corporation | 3 | $78 |
| Amgen Inc. | 3 | $61 |
| PFIZER INC. | 2 | $36 |
Products named: JARDIANCE, QULIPTA, Veozah, WINREVAIR, UBRELVY, SHINGRIX, Cologuard Collection Kit, OTEZLA.
Industry payments across CT — which companies pay providers there.
